The Corner

Geron Abandons Embryonic-Stem-Cell Research

 

Geron Corporation was the big hope for embryonic-stem-cell research. After years of promises, its first-ever human trial using an embryonic-stem-cell-derived product for acute spinal-cord injury made huge headlines internationally. But now, the Washington Post is reporting that Geron has abandoned the field altogether. 

This is an atom bomb of a story that will have a serious effect on the entire regenerative medical sector. And it should embarrass the critics of President Bush; the California Institute for Regenerative Medicine, which bragged about its part in funding a scientist involved in the research; and, perhaps most of all, the fawning media that have acted as press agent for both the field generally, and Geron specifically.

Most Popular

U.S.

Regular Order

Jussie Smollett’s story has always sounded a little . . . extraordinary. Smollett, who appears on the television series Empire, says he was attacked on the streets of Chicago at 2 a.m. by two men who shouted racial and homophobic abuses at him, beat him, doused him with bleach, and fastened a noose around ... Read More